Literature DB >> 6433346

Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

T W Chang, S McKinney, V Liu, P C Kung, J Vilcek, J Le.   

Abstract

Mouse monoclonal antibodies B1 and B3 are specific for natural and Escherichia coli-derived recombinant human gamma-interferon (IFN-gamma). The two antibodies recognize different epitopes of the IFN-gamma molecule and do not compete with each other's binding. We have used these two antibodies to construct a solid-phase, sandwich immunoradiometric assay for human IFN-gamma. Purified antibody B1 was coated on polystyrene beads (0.64 cm in diameter) and used as the solid-phase immunoadsorbent and antibody B3 was labeled with 125I and used as tracer. This assay can be completed in about 4 hr and is capable of detecting IFN-gamma levels in human serum or tissue culture fluids as low as 0.1 NIH reference unit/ml. Recombinant human IFN-gamma derived from E. coli was detectable at a concentration of 0.02 ng/ml. The assay appears to be specific for the biologically active forms of IFN-gamma, since after exposure to pH 2, 37 degrees C, or 56 degrees C, biological activity and reactivity in the immunoradiometric assay decreased in parallel. The immunoradiometric assay can be employed for the analysis of the structural characteristics of the human IFN-gamma molecule.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433346      PMCID: PMC391669          DOI: 10.1073/pnas.81.16.5219

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Production of high-titered interferon in cultures of human diploid cells.

Authors:  E A Havell; J Vilcek
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

2.  Polystyrene balls as the solid-phase of a double-antibody radioimmunoassay for human serum albumin.

Authors:  B R Ziola; M T Matikainen; A Salmi
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

3.  Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response.

Authors:  H M Johnson; G J Stanton; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1977-01

4.  In vitro interactions of purified cloned human interferons on NK cells: enhanced activation.

Authors:  S Targan; N Stebbing
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

5.  Molecular weight of human gamma interferon is similar to that of other human interferons.

Authors:  Y K Yip; B S Barrowclough; C Urban; J Vilcek
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

6.  Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin.

Authors:  P S Steeg; H M Johnson; J J Oppenheim
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Spontaneous production of gamma-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease.

Authors:  N Fujii; T Minagawa; A Nakane; F Kato; S Ohno
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus.

Authors:  F A Ennis; A Meager
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  36 in total

1.  Presence of gamma interferon in human acute and congenital toxoplasmosis.

Authors:  J Raymond; M H Poissonnier; P H Thulliez; F Forestier; F Daffos; P Lebon
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Interferon gamma in acute and subacute encephalitis.

Authors:  P Lebon; B Boutin; O Dulac; G Ponsot; M Arthuis
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

3.  The role of interferon gamma in the pathogenesis of Crohn's disease.

Authors:  T Sasaki; N Hiwatashi; H Yamazaki; M Noguchi; T Toyota
Journal:  Gastroenterol Jpn       Date:  1992-02

4.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

5.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

6.  MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.

Authors:  S Stemme; G Fager; G K Hansson
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

7.  Functional characterization of SV40-transformed adherent synovial cells from rheumatoid arthritis.

Authors:  M Goto; M Okamoto; M Sasano; K Nishizawa; S Aotsuka; N Yamaguchi; M Obinata; K Ikeda
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

8.  Serum levels of interferons in patients with systemic lupus erythematosus.

Authors:  T Kim; Y Kanayama; N Negoro; M Okamura; T Takeda; T Inoue
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

9.  Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.

Authors:  C D Kelly; C M Russo; B Y Rubin; H W Murray
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

10.  Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.

Authors:  A M Liberati; M Horisberger; M Schippa; F Di Clemente; M Fizzotti; S Filippo; M G Proietti; S Arzano; P Berruto; L Palmisano
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.